化学
神经节苷脂
结合
免疫疗法
黑色素瘤
癌症研究
脂质A
免疫学
癌症免疫疗法
药理学
结合疫苗
病毒学
癌症疫苗
接种疫苗
作者
Ruxin Liang,Yifan Ye,H Liu,Xiaohui Li,Lingqiang Gao,Hanyu Li,Deying Yang,Wenbo Ming,Zhongqiu Liu,Xiang Luo,Guochao Liao
标识
DOI:10.1021/acs.jmedchem.6c00625
摘要
Ganglioside GM3 is a well-established cutaneous melanoma-associated carbohydrate antigen. Efforts toward its clinical translation as a cancer vaccine have been hampered by poor immunogenicity. This study describes the design and synthesis of a fully synthetic self-adjuvanting GM3-based conjugate vaccine ( 1 ) using lipid A mimetics as a carrier. Immunological evaluations demonstrated that conjugate 1 effectively elicited GM3-specific immune responses. The antisera induced by this conjugate recognized, bound to, and facilitated the destruction of GM3-positive cancer cells. Combination with the adjuvants QS-21 and EcMPLA dramatically enhanced the immunogenicity and antitumor efficacy of conjugate 1 at a dose of 2 μg of GM3 per mouse. The IgG titers of 1 /EcMPLA/QS-21 were more than twice those of GM3-KLH/Al. Furthermore, 1 /EcMPLA/QS-21 conferred strong protection in tumor-challenge models, significantly delaying tumor growth and extending survival. These findings demonstrate the potential of conjugate 1 combined with EcMPLA and QS-21 as a candidate vaccine for melanoma immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI